Oji Holdings Corporation announces that it has acquired shares in Chemfield Cellulose Private Limited, a premier manufacturer of microcrystalline cellulose (MCC) based in India. This strategic move reinforces Oji’s commitment to high-value-added businesses by integrating its world-class wood pulp production with advanced pharmaceutical excipient solutions. The acquisition price remains undisclosed.
Microcrystalline cellulose is a refined, high-purity cellulose powder that serves as a critical excipient in pharmaceutical formulations.
Through this acquisition, Oji Holdings will leverage its expertise in sustainable forest resource management and pulp production to create a unique “Tree to Tablet” supply chain enhancing quality, traceability, and environmental responsibility in pharmaceutical excipient manufacturing.
Going forward, Oji Group aims to expand its high-value-added business by establishing an integrated production and sales system for pulp-derived products, such as MCC, as a downstream extension of its existing pulp raw material business.
